The TRUPCR® AML Panel Kit is intended for the qualitative detection of diagnostic and prognostic markers of acute myelogenous leukaemia (AML) in peripheral blood samples on conventional and Real-time PCR technologies. Acute myeloid leukaemia (AML) is a group of haematological diseases, phenotypic and genetically heterogeneous, characterized by clonal expansion of myeloid precursors with diminished capacity for differentiation. AML represents 15 to 20% of acute leukaemia cases in children and 80% in adults. Myelogenous leukaemia is present when myeloid cell lineages such as granulocytes or monocytes are affected.
TRUPCR® AML panel Kit is a combination of conventional PCR and Real-time PCR. TRUPCR® AML Panel kit is a comprehensive kit which includes complete cDNA chemistry for RNA based transcripts.